Advertisement

Latest Articles

  • Open Access
    α6-Containing GABAA Receptors: Functional Roles and Therapeutic Potentials
    Werner Sieghart, Lih-Chu Chiou, Margot Ernst, Jure Fabjan, Miroslav M. Savić and Ming Tatt Lee
    Charles France, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 238-270; DOI: https://doi.org/10.1124/pharmrev.121.000293
  • Neurobiological Mechanisms of Nicotine Reward and Aversion
    Open Access
    Neurobiological Mechanisms of Nicotine Reward and Aversion
    Lauren Wills, Jessica L. Ables, Kevin M. Braunscheidel, Stephanie P.B. Caligiuri, Karim S. Elayouby, Clementine Fillinger, Masago Ishikawa, Janna K. Moen and Paul J. Kenny
    Charles France, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 271-310; DOI: https://doi.org/10.1124/pharmrev.121.000299
  • Inhaled Medicines: Past, Present, and Future
    Open Access
    Inhaled Medicines: Past, Present, and Future
    Sandra Anderson, Paul Atkins, Per Bäckman, David Cipolla, Andrew Clark, Evangelia Daviskas, Bernd Disse, Plamena Entcheva-Dimitrov, Rick Fuller, Igor Gonda, Hans Lundbäck, Bo Olsson and Jeffry Weers
    Clive Page, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 48-118; DOI: https://doi.org/10.1124/pharmrev.120.000108
  • The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Open Access
    The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein
    Lauren M. Lucas, Vipasha Dwivedi, Jared I. Senfeld, Richard L. Cullum, Christopher P. Mill, J. Tyler Piazza, Ianthe N. Bryant, Laura J. Cook, S. Tyler Miller, James H. Lott, Connor M. Kelley, Elizabeth L. Knerr, Jessica A. Markham, David P. Kaufmann, Megan A. Jacobi, Jianzhong Shen and David J. Riese
    Eric Barker, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 18-47; DOI: https://doi.org/10.1124/pharmrev.121.000381
  • Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
    Vincent Pons and Serge Rivest
    Robert Dantzer, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 1-17; DOI: https://doi.org/10.1124/pharmrev.121.000400
  • Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
    Céline Nicolas, Natalie E. Zlebnik, Mehdi Farokhnia, Lorenzo Leggio, Satoshi Ikemoto and Yavin Shaham
    Michael Nader, ASSOCIATE EDITOR
    Pharmacological Reviews January 2022, 74 (1) 119-140; DOI: https://doi.org/10.1124/pharmrev.121.000367
  • Aldo-Keto Reductases and Cancer Drug Resistance
    Open Access
    Aldo-Keto Reductases and Cancer Drug Resistance
    Trevor M. Penning, Sravan Jonnalagadda, Paul C. Trippier and Tea Lanišnik Rižner
    Michael Gottesman, ASSOCIATE EDITOR
    Pharmacological Reviews July 2021, 73 (3) 1150-1171; DOI: https://doi.org/10.1124/pharmrev.120.000122
  • Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
    Roger L. Papke and Nicole A. Horenstein
    Habibeh Khoshbouei, ASSOCIATE EDITOR
    Pharmacological Reviews July 2021, 73 (3) 1118-1149; DOI: https://doi.org/10.1124/pharmrev.120.000097
  • Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Michael J. Lucido, Mandy Bekhbat, David R. Goldsmith, Michael T. Treadway, Ebrahim Haroon, Jennifer C. Felger and Andrew H. Miller
    Robert Dantzer, ASSOCIATE EDITOR
    Pharmacological Reviews July 2021, 73 (3) 1084-1117; DOI: https://doi.org/10.1124/pharmrev.120.000043
  • Animal Models of Drug Relapse and Craving after Voluntary Abstinence: A Review
    Ida Fredriksson, Marco Venniro, David J. Reiner, Jonathan J. Chow, Jennifer M. Bossert and Yavin Shaham
    Michael Nader, ASSOCIATE EDITOR
    Pharmacological Reviews July 2021, 73 (3) 1050-1083; DOI: https://doi.org/10.1124/pharmrev.120.000191

Pages